China Emerging As Big Winner In Pharma Outsourcing Rush To Asia - PwC
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Asia's expanding wealth and markets for drugs, combined with a pool of scientific talent and strengthening protections for patents, are propelling pharmaceutical multinationals to step up operations in the region in drug manufacturing, research and clinical trials